Company profilePharmaceutical#338 of 1,318 in Pakistan✓ No DRAP alerts

SWAN PHARMACEUTICALS(PVT) LTD

Pharmaceutical company · 52 brands · 53 molecules

52 registered products 16 pharmaceutical brands 53 distinct molecules 0 DRAP alerts

Company overview

52
registered products
16
pharmaceutical brands
53
distinct molecules
0
therapeutic classes
0
DRAP alerts

SWAN PHARMACEUTICALS(PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 52 product registrations across 53 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SWAN

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 51.48 – Rs 51.48
Median across source: Rs 51.48

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac
GENOME PHARMACEUTICALS (PVT) LTD holds 112 molecules not in this portfolio
AcitretinAmlodipineAnastrazoleAnastrozoleAprepitantArtemether
BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate

Get the full profile for SWAN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.